Avantor, Inc. (NYSE:AVTR) Shares Purchased by Norris Perne & French LLP MI

Norris Perne & French LLP MI lifted its holdings in Avantor, Inc. (NYSE:AVTR) by 2.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 480,117 shares of the company’s stock after purchasing an additional 13,047 shares during the period. Norris Perne & French LLP MI owned approximately 0.07% of Avantor worth $12,277,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Vontobel Holding Ltd. grew its holdings in shares of Avantor by 2.0% in the fourth quarter. Vontobel Holding Ltd. now owns 30,215 shares of the company’s stock valued at $690,000 after purchasing an additional 591 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its stake in Avantor by 3.8% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 18,725 shares of the company’s stock worth $427,000 after acquiring an additional 685 shares during the last quarter. Fifth Third Bancorp lifted its stake in Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after acquiring an additional 694 shares during the last quarter. Mackenzie Financial Corp lifted its stake in Avantor by 1.6% in the fourth quarter. Mackenzie Financial Corp now owns 46,610 shares of the company’s stock worth $1,064,000 after acquiring an additional 747 shares during the last quarter. Finally, Xponance Inc. lifted its stake in Avantor by 3.4% in the fourth quarter. Xponance Inc. now owns 26,254 shares of the company’s stock worth $599,000 after acquiring an additional 858 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AVTR. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, April 29th. Barclays decreased their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday. Evercore ISI lifted their price target on shares of Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, April 18th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $26.36.

Avantor Stock Performance

AVTR stock traded down $0.22 on Friday, hitting $21.20. The company’s stock had a trading volume of 9,536,567 shares, compared to its average volume of 6,872,663. The firm has a 50 day moving average of $23.73 and a two-hundred day moving average of $23.79. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $26.16. The stock has a market cap of $14.40 billion, a price-to-earnings ratio of 54.36, a price-to-earnings-growth ratio of 2.17 and a beta of 1.35. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.94.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm earned $0.29 EPS. Avantor’s revenue for the quarter was down 5.6% on a year-over-year basis. Equities analysts predict that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.